Lilly VP Says U.S. Backing Off 12-Year Protection For Biologics In TPP
This article was originally published in PharmAsia News
Executive Summary
An Eli Lilly official said the U.S. administration has been reluctant to press for data protection for biologic drugs in 11-nation free trade Pacific Rim talks set to be held in December.